Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma - Publication - Bridge of Knowledge

Search

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

Abstract

Citations

  • 1 0 0

    CrossRef

  • 0

    Web of Science

  • 1 0 7

    Scopus

Authors (14)

  • Photo of  W Jurczak

    W Jurczak

  • Photo of  P Zinzani

    P Zinzani

  • Photo of  G Gaidano

    G Gaidano

  • Photo of  A Goy

    A Goy

  • Photo of  M Provencio

    M Provencio

  • Photo of  Z Nagy

    Z Nagy

  • Photo of  T Robak

    T Robak

  • Photo of  K Maddocks

    K Maddocks

  • Photo of  C Buske

    C Buske

  • Photo of  S Ambarkhane

    S Ambarkhane

  • Photo of  M Winderlich

    M Winderlich

  • Photo of  M Dirnberger-Hertweck

    M Dirnberger-Hertweck

  • Photo of  R Korolkiewicz

    R Korolkiewicz

  • Photo of  K Blum

    K Blum

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
ANNALS OF ONCOLOGY no. 29, edition 5, pages 1266 - 1272,
ISSN: 0923-7534
ISSN:
0923-7534
Publication year:
2018
DOI:
Digital Object Identifier (open in new tab) 10.1093/annonc/mdy056
Verified by:
No verification

seen 97 times

Meta Tags